论文信息 - Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2+) metastatic breast cancer (MBC). - 字舞流文

Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2+) metastatic breast cancer (MBC).

M. Gnant | Z. Bago-Horvath | P. Dubsky | F. Fitzal | G. Steger | C. Wenzel | R. Bartsch | C. Zielinski | M. Rudas | U. Pluschnig | A. Berghoff | K. Dieckmann | A. Rottenfusser